Concepedia

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

Joan T. Merrill, Ronald van Vollenhoven, Jill P. Buyon, Richard Furie, William Stohl, MA Morgan-Cox, C. Dickson, Pamela W. Anderson, Calvin Lee, Thomas Dörner

Annals of the Rheumatic Diseases · 2015 · 224 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +11

The rapid assessment of fatigue severity in cancer patients

Tito R. Mendoza, X. Shelley Wang, Charles S. Cleeland et al. · Cancer · 1999 · 1.8K citations · Full text

, , +16

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.7K citations · Full text

, , +17

BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

Pascal Schneider, Fabienne Mackay, Véronique Steiner et al. · The Journal of Experimental Medicine · 1999 · 1.3K citations · Full text

, , +17

Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus

Michelle Petri, Mimi Kim, Kenneth Kalunian et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

, , +17